- recruitingTherapeutic confirmatory (Phase III)
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of REL-1017 as Adjunctive Treatment for Major Depressive Disorder - SM-1
This study is looking at a new medication, REL-1017, to help people with major depression who haven't fully improved with their current treatment. It's comparing the new drug to a dummy pill to see if it makes a difference to their mood.
Italy - recruitingNA
Validation of a Composite Medical Device Using a Blood Biomarker-based Algorithm and MDQ for the Diagnosis of Bipolar Disorder
This study is testing a new way to diagnose bipolar disorder more accurately in adults who are feeling very low. It uses a blood test and a questionnaire to see if it can tell the difference between bipolar disorder and other types of depression.
France - recruitingNA
Skills for Wellness
This study, 'Skills for Wellness', helps young people (9-21) at high risk of severe mental illness like schizophrenia or bipolar disorder. It tests a new talking therapy called maCBT to prevent these conditions by teaching skills to manage early warning signs like anxiety or unusual experiences.
Canada - not yet recruiting
Individual Narratives of Stimulation (ECT and TMS)
This study explores the experiences of people in Nottingham and Liverpool who have received both electroconvulsive therapy (ECT) and transcranial magnetic stimulation (TMS) for severe depression. We want to understand their stories to help improve future treatments and support for others.
United Kingdom